A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia

NCT01942161 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Aripiprazole Low (2 mg/day)
DRUG: Aripiprazole Mid (6 - 12 mg/day)
DRUG: Aripiprazole High (24 - 30 mg/day)

Sponsor

Otsuka Pharmaceutical Co., Ltd.